10-Attachment B - Pricing Schedule.xlsx

This pricing schedule attachment establishes the cost structure for Employee Drug and Disease Testing Services for the Harris County Hospital District dba Harris Health (RFO AB02042026) in Texas. The contract covers comprehensive testing services including pre-employment, post-accident, random, and for-cause testing for applicants and employees. The pricing schedule itemizes individual unit costs for numerous testing services, including urine drug screens (collected by Harris Health or at vendor location), oral fluid/saliva drug screens, breath alcohol tests, immunological panels (MMR titer, Varicella IgG, Hepatitis B Surface Antibody), Interferon-Gamma Release Assay for TB, specimen collection fees, urgent test bundles, Medical Review Officer reviews for positive results, shipping, and after-hours call-out fees. The estimated annual quantities range from 30 to 2,550 units depending on the test type. The contract term is scheduled to begin in April 2026 and continue for twelve months.

The pricing structure requires vendors to provide guaranteed all-inclusive pricing that covers all costs, supplies, shipping, standard reporting, and Medical Review Officer services without separate charges or adjustments based on patient volume during the contract period. Harris Health reserves the right to purchase quantities greater or less than those estimated in the schedule. Any annual price escalations are capped at the Bureau of Labor Statistics Consumer Price Index (CPI) for "All items in U.S. city average, all urban consumers, not seasonally adjusted," calculated as the difference between the current year and prior year CPI, applied only at annual renewal periods. The analyte list for drug screens must match Harris Health's specified 12-panel configuration (6-AM, fentanyl, barbiturates, benzodiazepines, cocaine, MDMA, marijuana metabolites, methadone, opiates, oxycodone, PCP, and propoxyphene).